Research Article
BibTex RIS Cite

Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel marker of endothelial dysfunction related to hypertension in aging

Year 2021, Volume: 10 Issue: 1, 104 - 111, 30.04.2021
https://doi.org/10.47493/abantmedj.2021.39

Abstract

References

  • 1. Herrera MD, Mingorance C, Rodríguez-Rodríguez R et al (2010) Endothelial dysfunction and aging: an update. Ageing Res Rev. 9: 142-152.
  • 2. Navarra T, Del Turco S, Berti S et al (2010) The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 17: 317-331.
  • 3. Lubrano V, Balzan S (2014) LOX-1 and ROS, inseparable factors in the process of endothelial damage. Free Radic Res. 48: 841-848
  • 4. Cakatay U, Kayali R, Uzun H (2008) Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med. 8: 51-57.
  • 5. Otsuki T, Maeda S, Mukai J et al (2015) Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals. J Clin Biochem Nutr. 57: 151-155.
  • 6. Oliveira-Paula GH, Lacchini R, Tanus-Santos JE (2014) Inducible nitric oxide synthase as a possible target in hypertension. Curr Drug Targets. 15: 164-174.
  • 7. Cau SB, Carneiro FS, Tostes RC (2012) Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol. 3: 218.
  • 8. Glenn CL, Wang WY, Morris BJ (1999) Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension. 33:927-932.
  • 9. Mehta JL (2004) The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. Can J Cardiol. 20: 32-36.
  • 10. Huang H, Koelle P, Fendler M et al (2014) Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis. 235:213-222.
  • 11. Itabe H (2003). Oxidized low density lipoprotein: what is understood and what remains to be clarified. Biol Pharm Bull. 26:1–9.
  • 12. Besir, Fahri Halit, et al. "Normal values correlates' of carotid intima-media thickness and affecting parameters in healthy adults/Saglikli eriskinlerde karotis intima-media kalinliginin normal degerleri ve etkileyen parametreler." The Anatolian Journal of Cardiology (Anadolu Kardiyoloji Dergisi) 12.5 (2012): 427-434.
  • 13. Yavuzer, S., Yavuzer, H., Cengiz, M., Erman, H., Altıparmak, M. R., Korkmazer, B.et al. (2015). Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. Journal of human hypertension, 29(2), 92-98.
  • 14. Taddei S, Virdis A, Ghiadoni L (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 38: 274–279.
  • 15. Kataoka H, Kume N, Miyamoto S et al (1999) Expression of lectin like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 99: 3110-3117.
  • 16. Yavuzer S, Yavuzer H, Cengiz M et al (2016). The role of protein oxidation and DNA damage in elderly hypertension. Aging Clin Exp Res. 28: 625-632.
  • 17. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation. 109: III27- III32.
  • 18. Braga M, Sinha Hikim AP, Datta S et al (2008) Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis. 13: 822–832.
  • 19. Di Massimo C1, Scarpelli P, Di Lorenzo N et al (2006) Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 78: 1163-1167.
  • 20. Pie JE, Baek SY, Kim HP et al (2002) Age-related decline of inducible nitric oxide synthase gene expression in primary cultured rat hepatocytes. Mol Cells. 13: 399-406.
  • 21. Alusik S, Jedlickova V, Paluch Z et al (2008) Plasma levels of nitrite/nitrate and inflammation markers in elderly individuals. Bratisl Lek Listy. 109: 289-292.
  • 22. Eichhorn B, Muller G, Leuner A et al (2009) Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res. 82: 493–502.
  • 23. Xu X, Gao X, Potter BJ et al (2007) Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol. 27: 871–877.
  • 24. Torregrossa AC, Aranke M, Bryan NS (2011) Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol. 8: 230-242.

Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1

Year 2021, Volume: 10 Issue: 1, 104 - 111, 30.04.2021
https://doi.org/10.47493/abantmedj.2021.39

Abstract

Amaç: Çözünebilir lektin benzeri oksitlenmiş düşük yoğunluklu lipoprotein reseptörü-1 (sLOX-1), oksitlenmiş düşük yoğunluklu lipoproteinin (oksLDL), nitrik oksit (NO) ve indüklenebilir nitrik oksit sentaz (iNOS) ve karotis intima-media kalınlığının (CIMT) yaşlanma ve hipertansiyondaki (HT) rolünü araştırmaktır.

Materyal ve Metot: Her biri 30 katılımcıdan oluşan; yaşlı HT, genç HT, yaşlı kontroller ve genç kontrollerin sLOX-1, oxLDL, CIMT, iNOS ve NO değerleri karşılaştırıldı.

Bulgular: sLOX-1 ve oxLDL düzeyleri hipertansif gruplarda kontrol gruplarına göre anlamlı olarak daha yüksekti. Yaş ile sLOX-1 ve CIMT arasında pozitif korelasyon saptandı. sLOX-1, oxLDL, CIMT, iNOS, sistolik kan basıncı ve diyastolik kan basıncı arasında pozitif, sLOX-1 ise NO ile negatif korelasyon saptandı. Regresyon analizinde, CIMT ve oxLDL'nin hipertansiyon üzerinde en etkili faktörler olduğu saptandı.

Tartışma ve Sonuç: Bu çalışma sLOX-1 ile ilişkili oksidasyon yolaklarının ve endotel disfonksiyonunun yaşlanma ile ilişkili HT riskini artırabileceğini göstermektedir. Nitrik oksit eksikliği yaşlılarda sLOX-1 ekspresyonunu artırabilir, bu da hipertansiyonda daha fazla sLOX-1 aracılı NO eksikliğine yol açar. Bu döngünün NO azalması veya sLOX-1 ve iNOS aktivitesinin aktivasyonu ile tetiklenip tetiklenmediğini değerlendirmek için daha fazla çalışmaya ihtiyaç vardır.

References

  • 1. Herrera MD, Mingorance C, Rodríguez-Rodríguez R et al (2010) Endothelial dysfunction and aging: an update. Ageing Res Rev. 9: 142-152.
  • 2. Navarra T, Del Turco S, Berti S et al (2010) The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 17: 317-331.
  • 3. Lubrano V, Balzan S (2014) LOX-1 and ROS, inseparable factors in the process of endothelial damage. Free Radic Res. 48: 841-848
  • 4. Cakatay U, Kayali R, Uzun H (2008) Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med. 8: 51-57.
  • 5. Otsuki T, Maeda S, Mukai J et al (2015) Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals. J Clin Biochem Nutr. 57: 151-155.
  • 6. Oliveira-Paula GH, Lacchini R, Tanus-Santos JE (2014) Inducible nitric oxide synthase as a possible target in hypertension. Curr Drug Targets. 15: 164-174.
  • 7. Cau SB, Carneiro FS, Tostes RC (2012) Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol. 3: 218.
  • 8. Glenn CL, Wang WY, Morris BJ (1999) Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension. 33:927-932.
  • 9. Mehta JL (2004) The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. Can J Cardiol. 20: 32-36.
  • 10. Huang H, Koelle P, Fendler M et al (2014) Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis. 235:213-222.
  • 11. Itabe H (2003). Oxidized low density lipoprotein: what is understood and what remains to be clarified. Biol Pharm Bull. 26:1–9.
  • 12. Besir, Fahri Halit, et al. "Normal values correlates' of carotid intima-media thickness and affecting parameters in healthy adults/Saglikli eriskinlerde karotis intima-media kalinliginin normal degerleri ve etkileyen parametreler." The Anatolian Journal of Cardiology (Anadolu Kardiyoloji Dergisi) 12.5 (2012): 427-434.
  • 13. Yavuzer, S., Yavuzer, H., Cengiz, M., Erman, H., Altıparmak, M. R., Korkmazer, B.et al. (2015). Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. Journal of human hypertension, 29(2), 92-98.
  • 14. Taddei S, Virdis A, Ghiadoni L (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 38: 274–279.
  • 15. Kataoka H, Kume N, Miyamoto S et al (1999) Expression of lectin like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 99: 3110-3117.
  • 16. Yavuzer S, Yavuzer H, Cengiz M et al (2016). The role of protein oxidation and DNA damage in elderly hypertension. Aging Clin Exp Res. 28: 625-632.
  • 17. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation. 109: III27- III32.
  • 18. Braga M, Sinha Hikim AP, Datta S et al (2008) Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis. 13: 822–832.
  • 19. Di Massimo C1, Scarpelli P, Di Lorenzo N et al (2006) Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 78: 1163-1167.
  • 20. Pie JE, Baek SY, Kim HP et al (2002) Age-related decline of inducible nitric oxide synthase gene expression in primary cultured rat hepatocytes. Mol Cells. 13: 399-406.
  • 21. Alusik S, Jedlickova V, Paluch Z et al (2008) Plasma levels of nitrite/nitrate and inflammation markers in elderly individuals. Bratisl Lek Listy. 109: 289-292.
  • 22. Eichhorn B, Muller G, Leuner A et al (2009) Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res. 82: 493–502.
  • 23. Xu X, Gao X, Potter BJ et al (2007) Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol. 27: 871–877.
  • 24. Torregrossa AC, Aranke M, Bryan NS (2011) Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol. 8: 230-242.
There are 24 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Research Articles
Authors

Muhammed Emin Demirkol 0000-0001-6262-6103

Serap Yavuzer 0000-0001-7618-9987

Mahir Cengiz 0000-0003-3343-8650

Bora Korkmazer 0000-0001-7015-365X

Huriye Balcı 0000-0002-6538-4514

Hafize Uzun 0000-0002-1347-8498

Alper Döventaş 0000-0001-5509-2625

Hakan Yavuzer 0000-0003-2685-6555

Publication Date April 30, 2021
Submission Date October 14, 2020
Published in Issue Year 2021 Volume: 10 Issue: 1

Cite

APA Demirkol, M. E., Yavuzer, S., Cengiz, M., Korkmazer, B., et al. (2021). Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1. Abant Medical Journal, 10(1), 104-111. https://doi.org/10.47493/abantmedj.2021.39
AMA Demirkol ME, Yavuzer S, Cengiz M, Korkmazer B, Balcı H, Uzun H, Döventaş A, Yavuzer H. Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1. Abant Med J. April 2021;10(1):104-111. doi:10.47493/abantmedj.2021.39
Chicago Demirkol, Muhammed Emin, Serap Yavuzer, Mahir Cengiz, Bora Korkmazer, Huriye Balcı, Hafize Uzun, Alper Döventaş, and Hakan Yavuzer. “Yaşlanma Ve Hipertansiyonda Yeni Bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1”. Abant Medical Journal 10, no. 1 (April 2021): 104-11. https://doi.org/10.47493/abantmedj.2021.39.
EndNote Demirkol ME, Yavuzer S, Cengiz M, Korkmazer B, Balcı H, Uzun H, Döventaş A, Yavuzer H (April 1, 2021) Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1. Abant Medical Journal 10 1 104–111.
IEEE M. E. Demirkol, S. Yavuzer, M. Cengiz, B. Korkmazer, H. Balcı, H. Uzun, A. Döventaş, and H. Yavuzer, “Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1”, Abant Med J, vol. 10, no. 1, pp. 104–111, 2021, doi: 10.47493/abantmedj.2021.39.
ISNAD Demirkol, Muhammed Emin et al. “Yaşlanma Ve Hipertansiyonda Yeni Bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1”. Abant Medical Journal 10/1 (April 2021), 104-111. https://doi.org/10.47493/abantmedj.2021.39.
JAMA Demirkol ME, Yavuzer S, Cengiz M, Korkmazer B, Balcı H, Uzun H, Döventaş A, Yavuzer H. Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1. Abant Med J. 2021;10:104–111.
MLA Demirkol, Muhammed Emin et al. “Yaşlanma Ve Hipertansiyonda Yeni Bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1”. Abant Medical Journal, vol. 10, no. 1, 2021, pp. 104-11, doi:10.47493/abantmedj.2021.39.
Vancouver Demirkol ME, Yavuzer S, Cengiz M, Korkmazer B, Balcı H, Uzun H, Döventaş A, Yavuzer H. Yaşlanma ve Hipertansiyonda Yeni bir Endoltelyal Disfonksiyon Belirteci: Çözünebilir Lektin Benzeri Okside Düşük Dansiteli Lipoprotein-1. Abant Med J. 2021;10(1):104-11.